Cargando…
The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib
Our previous studies have demonstrated that sorafenib can promote the dissemination of hepatocellular carcinoma (HCC) through downregulation of HTATIP2, a suppressor of tumor growth and metastasis that is associated with inhibition of angiogenesis. Here, we investigated the predictive values of the...
Autores principales: | Wang, Wen-Quan, Liu, Liang, Xu, Hua-Xiang, Sun, Hui-Chuan, Wu, Chun-Tao, Zhu, Xiao-Dong, Zhang, Wei, Xu, Jin, Liu, Chen, Long, Jiang, Ni, Quan-Xing, Tang, Zhao-You, Yu, Xian-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116529/ https://www.ncbi.nlm.nih.gov/pubmed/25008315 |
Ejemplares similares
-
Aspirin Minimized the Pro-Metastasis Effect of Sorafenib and Improved Survival by Up-Regulating HTATIP2 in Hepatocellular Carcinoma
por: Lu, Lu, et al.
Publicado: (2013) -
Microvessel Density and Clinicopathologic Characteristics in Hepatocellular Carcinoma With and Without Cirrhosis
por: Chebib, Ivan, et al.
Publicado: (2007) -
Correlation of adrenomedullin with the erythropoietin receptor and microvessel density in hepatocellular carcinoma
por: Qu, Zhen, et al.
Publicado: (2015) -
Tumor-associated antigen CAPERα and microvessel density in hepatocellular carcinoma
por: Dai, Liping, et al.
Publicado: (2016) -
Intratumoral α-SMA Enhances the Prognostic Potency of CD34 Associated with Maintenance of Microvessel Integrity in Hepatocellular Carcinoma and Pancreatic Cancer
por: Wang, Wen-Quan, et al.
Publicado: (2013)